NCT04908176 2024-12-13
A Drug-drug Interaction Study of Avapritinib and Midazolam
Blueprint Medicines Corporation
Phase 1 Completed
Blueprint Medicines Corporation
Blueprint Medicines Corporation
CStone Pharmaceuticals
Blueprint Medicines Corporation